Skip to content
★ Sign in to follow
CellSource Co.,Ltd. logo

CellSource Co.,Ltd. Stock: price and insider trades · Japan

セルソース株式会社

JP·Mcap JP¥6.2BHealth Care

CellSource Co.,Ltd.: what insiders have been doing

CellSource Co.,Ltd. belongs to the Health Care sector. Filings by its managers are published through EDINET (Japan FSA). Over the twelve months to 26 October 2026, 2 filings were filed, from 1 insider.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Over the last twelve months, not one insider purchase of CellSource Co.,Ltd. stock was filed.

Across the 3,205 companies tracked on its exchange, the median is 3 filings; at 2 filings, this issuer sits below that mark.

Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.

Insider Decl.
20
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 12,753 of 26,911 companies
52.8
score / 100
Value
41
Quality
64
FCF yld5.3%
Earn yld0.2%
EV/EBITDA17.6x
ROE·
Gross mgn56%
Net mgn0.3%
Debt/EBITDA0.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended October 2025 · cache

JP¥313
Analyst consensus
1 analysts
0.00/5
JP¥880Target JP¥880(+181%)JP¥880
Income statement
RevenueJP¥3.7B
Gross profitJP¥2.1B56% margin
EBITDAJP¥309.4M8% margin
Net incomeJP¥10.7M1.9% margin
Valuation
PER (trailing)63.0x
P/Book1.0x
Beta-0.01
Balance sheet & cash
Market capJP¥6.2B
Total debtJP¥56.7M
Free Cash FlowJP¥283M
Profitability & ownership
% insiders54.3%
% institutions4.1%
Last declaration on 16 September 2026
Declarations20 total
  • ●
    Large shareholderExecutives
    9EDINET
    10.9% of flowShareXTKSEDINET:S100Z2FY
  • ●
    Large shareholderExecutives
    6EDINET
    10.7% of flowShareXTKSEDINET:S100WDG3
  • ●
    Large shareholderExecutives
    6EDINET
    10.8% of flowShareXTKSEDINET:S100VP26
  • ●
    Large shareholderExecutives
    6EDINET
    11.1% of flowShareXTKSEDINET:S100V8BO
  • ●
    Large shareholderExecutives
    6EDINET
    10.8% of flowShareXTKSEDINET:S100T0S6
  • ●
    Large shareholderExecutives
    6EDINET
    12.0% of flowShareXTKSEDINET:S100T0XI
  • ●
    Large shareholderExecutives
    6EDINET
    11.0% of flowShareXTKSEDINET:S100S8GE
  • ●
    Large shareholderExecutives
    6EDINET
    12.3% of flowShareXTKSEDINET:S100S45I
  • ●
    Large shareholderExecutives
    6EDINET
    12.5% of flowShareXTKSEDINET:S100RZN2
  • ●
    Large shareholderExecutives
    6EDINET
    11.2% of flowShareXTKSEDINET:S100S0N6
  • ●
    Large shareholderExecutives
    6EDINET
    11.3% of flowShareXTKSEDINET:S100RXGC
  • ●
    Large shareholderExecutives
    6EDINET
    12.4% of flowShareXTKSEDINET:S100RXTE
  • ●
    OfficerExecutives
    12EDINET
    11.2% of flowShareXTKSEDINET:S100RU7W
  • ●
    Large shareholderExecutives
    6EDINET
    11.1% of flowShareXTKSEDINET:S100RTRH
  • ●
    Large shareholderExecutives
    6EDINET
    11.4% of flowShareXTKSEDINET:S100QYZL
  • ●
    Large shareholderExecutives
    6EDINET
    13.9% of flowShareXTKSEDINET:S100PU8Y
  • ●
    OfficerExecutives
    13EDINET
    15.2% of flowShareXTKSEDINET:S100PA4G
  • ●
    Large shareholderExecutives
    0EDINET
    32.3% of flowShareXTKSEDINET:S100PA4F
  • ●
    Unknown
    Large shareholderExecutives
    13EDINET
    100.0% of flowShareXTKSEDINET:S100NL0T
  • ●
    Unknown
    Large shareholderExecutives
    13EDINET
    2,736,000 shares100.0% of flowShareXTKSEDINET:S100N22M

20 of 20 declarations

About CellSource Co.,Ltd.

Celsource Inc. is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XTKS market.